Chandan Healthcare Limited (NSE:CHANDAN)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pathology	635.79M
Pathology Growth	35.89%
Pharmaceuticals	561.23M
Pharmaceuticals Growth	27.78%
Radiology	339.12M
Radiology Growth	18.30%
FMCG	157.82M
FMCG Growth	74.29%
Surgical	42.12M
Surgical Growth	-30.97%
Chandan Healthcare Limited	29.67M
Chandan Healthcare Limited Growth	26.04%
Other	151.00K
Other Growth	268.29%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
India	1.77B
India Growth	29.00%